(CAH) Cardinal Health - Ratings and Ratios

Exchange: NYSE • Country: United States • Currency: USD • Type: Common Stock • ISIN: US14149Y1082

CAH: Pharmaceuticals, Medical Supplies, Radiopharmaceuticals, Medical Devices, Procedure Kits

Cardinal Health Inc (NYSE:CAH) is a leading healthcare services and products company with operations spanning the United States, Canada, Europe, Asia, and other international markets. The company specializes in providing tailored solutions to a diverse range of healthcare entities, including hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and home healthcare settings. Organized into two primary segments—Pharmaceutical and Specialty Solutions, and Global Medical Products and Distribution—Cardinal Health offers a comprehensive suite of products and services. These include the distribution of branded, generic, and specialty pharmaceuticals, over-the-counter healthcare products, and medical supplies. Additionally, the company provides specialized services such as pharmacy management for hospitals, operation of community health center pharmacies, and repackaging of generic pharmaceuticals and over-the-counter products. Cardinal Health also manufactures and distributes a wide array of medical, surgical, and laboratory products under its own brand, including exam and surgical gloves, sharps disposal systems, wound care products, and surgical drapes. Furthermore, the company distributes national brand products, offers supply chain solutions, and assembles procedure kits for various healthcare providers. Cardinal Health also engages in the manufacture, preparation, and distribution of radiopharmaceuticals and related treatments, leveraging technology to optimize direct shipments. Established in 1979, the company is headquartered in Dublin, Ohio, and operates through a robust network that supports healthcare providers worldwide.

Cardinal Health Inc (NYSE:CAH) is forecasted to experience continued growth over the next three months, supported by its strong market position and diversified product offerings. Based on the technical data, the stock has shown resilience, trading above its 20-day and 50-day simple moving averages (SMA), which currently stand at 133.08 and 129.54, respectively. The 200-day SMA of 116.33 indicates a positive long-term trend, suggesting sustained upward momentum. The average true range (ATR) of 3.62 reflects moderate volatility, which may present opportunities for short-term traders. On the fundamental side, the companys market capitalization of $31.8 billion underscores its stability and scale. While the trailing P/E of 24.49 may indicate a premium valuation, the forward P/E of 14.64 suggests investor confidence in future earnings growth. The price-to-book (P/B) ratio of 16.07 highlights a rich valuation relative to book value, while the price-to-sales (P/S) ratio of 0.14 indicates efficient revenue generation. Despite a negative return on equity (RoE) of -43.80, which raises concerns about profitability, Cardinal Healths diversified business model and critical role in the healthcare supply chain position it for steady performance. Over the next quarter, the stock is likely to maintain its upward trajectory, driven by solid fundamentals and consistent execution, though investors should monitor valuation metrics and profitability trends.

Additional Sources for CAH Stock

CAH Stock Overview

Market Cap in USD 31,831m
Sector Healthcare
Industry Medical Distribution
GiC Sub-Industry Health Care Distributors
IPO / Inception 1987-12-31

CAH Stock Ratings

Growth Rating 94.6
Fundamental 44.3
Dividend Rating 46.7
Rel. Strength 34.4
Analysts 4/5
Fair Price Momentum 152.85 USD
Fair Price DCF 295.79 USD

CAH Dividends

Dividend Yield 12m 1.67%
Yield on Cost 5y 4.72%
Annual Growth 5y -4.84%
Payout Consistency 92.1%

CAH Growth Ratios

Growth Correlation 3m 52.6%
Growth Correlation 12m 93.8%
Growth Correlation 5y 94%
CAGR 5y 25.08%
CAGR/Max DD 5y 1.02
Sharpe Ratio 12m 1.70
Alpha 18.89
Beta 0.349
Volatility 23.47%
Current Volume 2826k
Average Volume 20d 2445.4k
What is the price of CAH stocks?
As of April 23, 2025, the stock is trading at USD 131.17 with a total of 2,825,994 shares traded.
Over the past week, the price has changed by -2.68%, over one month by -0.18%, over three months by +2.99% and over the past year by +29.84%.
Is Cardinal Health a good stock to buy?
Partly, yes. Based on ValueRay Fundamental Analyses, Cardinal Health (NYSE:CAH) is currently (April 2025) ok to buy, but has to be watched. It has a ValueRay Fundamental Rating of 44.34 and therefor a somewhat positive outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of CAH as of April 2025 is 152.85. This means that CAH is currently undervalued and has a potential upside of +16.53% (Margin of Safety).
Is CAH a buy, sell or hold?
Cardinal Health has received a consensus analysts rating of 4.00. Therefor, it is recommend to buy CAH.
  • Strong Buy: 8
  • Buy: 2
  • Hold: 6
  • Sell: 1
  • Strong Sell: 0
What are the forecast for CAH stock price target?
According to ValueRays Forecast Model, CAH Cardinal Health will be worth about 165.1 in April 2026. The stock is currently trading at 131.17. This means that the stock has a potential upside of +25.85%.
Issuer Forecast Upside
Wallstreet Target Price 142.2 8.4%
Analysts Target Price 132.1 0.7%
ValueRay Target Price 165.1 25.9%